Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023
Heska Corporation (NASDAQ: HSKA) will release its fourth quarter and full year 2022 financial results before market open on February 28, 2023. An earnings call is scheduled for 9 a.m. MT (11 a.m. ET) to discuss these results. Investors can access the call via telephone or through a live webcast on the company's investor relations website. A replay of the call will be available from 2 p.m. ET on the same day until March 14, 2023. Heska specializes in advanced veterinary diagnostic and specialty solutions, serving companion animal veterinarians across North America and internationally.
- None.
- None.
LOVELAND, Colo., Feb. 8, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its fourth quarter and full year 2022 financial performance in a press release before the market opens on Tuesday, February 28, 2023. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.
To access the conference call:
From within the United States, please dial 1-877-41-6152
From outside of the United States, please dial 1-201-389-0879
Reference Conference ID: 13736218
The earnings call will be webcast live from the Company's investor relations website at: Heska Fourth Quarter and Full Year Earnings Call Webcast.
A telephonic replay will be available at 2 p.m. ET on February 28th through 11:59 p.m. ET on March 14, 2023 and the webcast will be archived on the Company's website for 90 days.
To access the replay by telephone:
From within the United States, please dial 1-800-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 13736218
About Heska
Heska Corporation (NASDAQ: HSKA) sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners. Heska's portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products; digital cytology services; point-of-care digital imaging diagnostic products; local and cloud-based data services; practice information management software ("PIMS") and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines. Heska's primary focus is supporting companion animal veterinarians in providing care to their patients. Heska's business is composed of two operating and reportable segments: North America and International. North America consists of the United States, Canada and Mexico. International consists of geographies outside of North America, primarily in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The Company's strategic focus on point-of-care diagnostic laboratory and imaging products is included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory, and the International segment includes PIMS business and veterinary laboratories. For more information, please visit www.heska.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-fourth-quarter-and-full-year-2022-financial-results-and-earnings-call-scheduled-for-february-28-2023-301741596.html
SOURCE Heska Corporation
FAQ
When will Heska report its fourth quarter and full year 2022 financial results?
What time is the earnings call for Heska?
How can I access Heska's earnings call?
What is the conference ID for the Heska earnings call?
Will there be a replay of the Heska earnings call?
